Press Releases :: iBio Inc. (IBIO)

Skip to main content Skip to section navigation Skip to footer

Year

Category

Mar 26, 2020 4:20 pm EDT

iBio Supporting AzarGen Biotechnologies’ Development of a Rituximab Biosimilar

Mar 26, 2020 7:30 am EDT

iBio Announces Advancement of COVID-19 Vaccine Program

Mar 20, 2020 7:30 am EDT

iBio Joins the Alliance for Biosecurity

Mar 18, 2020 8:00 am EDT

iBio Announces Development of Proprietary COVID-19 Vaccine Candidates

Mar 12, 2020 4:45 pm EDT

iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO

Mar 2, 2020 4:30 pm EST

iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split

Feb 6, 2020 4:30 pm EST

iBio, Inc. Announces Postponement of Annual Meeting

Feb 3, 2020 4:15 pm EST

iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine

Jan 16, 2020 8:00 am EST

iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance

Jan 6, 2020 9:15 am EST

iBio Initiates New Litigation Against Fraunhofer